Lungs News and Research

RSS

NTU's new medical school to use plastinated human bodies for medical education

Nanyang Technological University's new medical school will be pioneering the use of plastinated bodies for medical education in Singapore.

27 May 2013

Scientists report new way of tackling cancer and predicting tumor virulence

A new way of tackling cancer and predicting tumor virulence are has been reported by a team of scientists from the Institut Albert Bonniot de Grenoble including researchers from CNRS, Inserm and Université Joseph Fourier, in collaboration with clinical physicians and anatomopathologists from the CHU de Grenoble, with the support of the Institut National du Cancer, the Ligue Nationale Contre le Cancer and the Fondation ARC pour la Recherche sur le Cancer.

26 May 2013

New study could help increase survival rates of people with colorectal tumours

Researchers from London's Kingston University have begun a two-year study which could help prolong the lives of people with colorectal tumours.

24 May 2013

Study suggests possible way to halt cancer development in premalignant cells

Scientists have uncovered a survival mechanism that occurs in breast cells that have just turned premalignant-cells on the cusp between normalcy and cancers-which may lead to new methods of stopping tumors.

24 May 2013

Researchers discover how drug prevents cancer progression

In collaboration with Daniel Zenklusen, also a University of Montreal biochemistry professor and lead author and doctoral candidate Vincent Messier, discovered that when cells are starved for nutrients TOR sends a signal to shut down production of a chemical message in the form of RNA to synthesize B cyclin ", Dr. Michnick explained.

24 May 2013

Common type of childhood asthma is not related to allergens and inflammation

Little is known about why asthma develops, how it constricts the airway or why response to treatments varies between patients. Now, a team of researchers at Weill Cornell Medical College, Columbia University Medical Center and SUNY Downstate Medical Center has revealed the roots of a common type of childhood asthma, showing that it is very different from other asthma cases.

24 May 2013

Researchers reveal roots of a common type of childhood asthma

24 May 2013

OncoGenex plans to initiate OGX-42 Phase 2 trial in patients with advanced squamous cell lung cancer

OncoGenex Pharmaceuticals, Inc. today announced plans for the initiation of the Cedar clinical trial, an investigator-sponsored, randomized, open-label Phase 2 trial evaluating OGX-427 in previously untreated patients with advanced squamous cell lung cancer.

23 May 2013

New drug delivery system can help treat lung cancer

Researchers have developed a new drug delivery system that allows inhalation of chemotherapeutic drugs to help treat lung cancer, and in laboratory and animal tests it appears to reduce the systemic damage done to other organs while significantly improving the treatment of lung tumors.

23 May 2013

Second annual conference to reduce genomic health disparities

Researchers in genomic health disparities from the University of Miami Miller School of Medicine and the Stanford University School of Medicine have teamed up to hold the second annual "Why We Can't Wait: Conference to Eliminate Health Disparities in Genomic Medicine."

23 May 2013

Innovative nebulizer to treat cystic fibrosis developed by Cambridge Consultants

Observing surfers with cystic fibrosis (CF) led scientists to discover that the inhaled mist of seawater has a therapeutic effect on the lung problems associated with the disease. Now the findings have been used by pharmaceutical company Parion Sciences and product development firm Cambridge Consultants in a revolutionary new aerosol delivery system. It enables CF sufferers to get the benefits of saltwater treatment in their own homes overnight while they sleep.

23 May 2013

National Council urges consumers to select sunscreen products that offer broad spectrum protection

As millions of Americans prepare to enjoy the great outdoors this Memorial Day weekend, the National Council on Skin Cancer Prevention has designated the Friday before Memorial Day, May 24, 2013, as "Don't Fry Day" to raise awareness of the importance of practicing sun-safe behaviors.

23 May 2013

Prosonix commences Phase 2 clinical study of PSX1002 for treatment of moderate to severe COPD

Prosonix, an innovative speciality pharmaceutical company developing a portfolio of inhaled Respiratory Medicines by Design, has initiated a Phase 2 clinical study with PSX1002 that will assess its effect on lung function and the safety of a range of doses in patients with moderate to severe chronic obstructive pulmonary disease.

23 May 2013

Researchers find that over 40% of patients treated for COPD did not actually have the disease

More than 40 percent of patients being treated for COPD at a federally funded clinic did not have the disease, researchers found after evaluating the patients with spirometry, the diagnostic "gold standard" for chronic obstructive pulmonary disease.

23 May 2013

MUC5B gene variation improves survival in patients with idiopathic pulmonary fibrosis

Variation in the gene MUC5B among patients with idiopathic pulmonary fibrosis was associated with improved survival, according to a study published online by JAMA. The study is being released early online to coincide with its presentation at the American Thoracic Society international conference.

22 May 2013

A1-PI treatment slows progression of emphysema in patients with AATD

Treatment with an Alpha-1 proteinase inhibitor (A1-PI), a naturally occurring protein that protects lung tissue from breakdown and protects the lung's elasticity, is effective in slowing the progression of emphysema in patients with Alpha-1 antitrypsin deficiency (AATD), a life-threatening genetic disorder, according to a new study presented at the 2013 American Thoracic Society International Conference.

22 May 2013

Genetic risk factor for pulmonary fibrosis can be used to identify individuals at risk for lung disease

A paper recently published in the New England Journal of Medicine and co-written by physicians and scientists at the University of Colorado School of Medicine finds that an important genetic risk factor for pulmonary fibrosis can be used to identify individuals at risk for this deadly lung disease.

22 May 2013

New study reveals racial differences in initial treatment of NSCLC

The surgical management of non-small cell lung cancer in U.S. hospitals varies widely depending on the race of the patient, according to a new study.

22 May 2013

Boehringer Ingelheim's tiotropium shows promising results in patients with severe persistent asthma

Boehringer Ingelheim today announced data from Phase 2 and Phase 3 studies from the Company's ongoing clinical trial program investigating the efficacy and safety of tiotropium in asthma. These data were presented at the American Thoracic Society International Conference in Philadelphia, Pennsylvania.

22 May 2013

LDCT helps identify earliest stages of lung cancer

A study of veterans at high risk for developing lung cancer shows that low-dose computed tomography can be highly effective in helping clinicians spot tiny lung nodules which, in a small number of patients, may indicate the earliest stages of the disease.

22 May 2013

Lungs News and Research

NTU's new medical school to use plastinated human bodies for medical education

Scientists report new way of tackling cancer and predicting tumor virulence

New study could help increase survival rates of people with colorectal tumours

Study suggests possible way to halt cancer development in premalignant cells

Researchers discover how drug prevents cancer progression

Common type of childhood asthma is not related to allergens and inflammation

Researchers reveal roots of a common type of childhood asthma

OncoGenex plans to initiate OGX-42 Phase 2 trial in patients with advanced squamous cell lung cancer

New drug delivery system can help treat lung cancer

Second annual conference to reduce genomic health disparities

Innovative nebulizer to treat cystic fibrosis developed by Cambridge Consultants

National Council urges consumers to select sunscreen products that offer broad spectrum protection

Prosonix commences Phase 2 clinical study of PSX1002 for treatment of moderate to severe COPD

Researchers find that over 40% of patients treated for COPD did not actually have the disease

MUC5B gene variation improves survival in patients with idiopathic pulmonary fibrosis

A1-PI treatment slows progression of emphysema in patients with AATD

Genetic risk factor for pulmonary fibrosis can be used to identify individuals at risk for lung disease

New study reveals racial differences in initial treatment of NSCLC

Boehringer Ingelheim's tiotropium shows promising results in patients with severe persistent asthma

LDCT helps identify earliest stages of lung cancer

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News